BTI Liquid 5% AS Procurement for State Public Health Departments in India Covering Biological Mosquito Larvicide Government Tenders, Vector Control Programmes, Technical Specifications, Product Registration

BTI Liquid 5% AS Procurement for State Public Health Mosquito Control Programmes

Bacillus thuringiensis subsp. israelensis (BTI) Liquid 5% AS is an aqueous suspension biological mosquito larvicide intended for controlling susceptible mosquito larvae in approved aquatic breeding environments. State public health departments, vector-borne disease control programmes, district health administrations and municipal health authorities may consider registered BTI liquid formulations as part of integrated mosquito management strategies. Biological larvicides are used to target susceptible larvae in breeding habitats, helping public health teams manage mosquito populations before adult emergence. Their suitability depends on the target mosquito species, breeding habitat, water conditions, product registration and approved label instructions.

State-level procurement planning may involve estimating treatment requirements across districts, municipalities, urban settlements and other areas covered by public health programmes. Purchasing authorities should assess the intended application sites, operational schedules, available field personnel and product storage requirements before establishing procurement quantities. BTI Liquid 5% AS should be evaluated as a formulation-specific product rather than treated as interchangeable with BTI WP 7% Powder or other larvicides. State departments should use applicable public procurement procedures and approved product specifications to ensure that purchasing decisions support operational needs, regulatory compliance and appropriate product quality.

Government Tender Procedures and Institutional Purchasing Requirements

State public health departments may procure mosquito control materials through the Government e-Marketplace (GeM), state e-procurement systems, departmental tenders or other purchasing methods permitted under applicable rules. Procurement notices may describe requirements for biological mosquito larvicides, mosquito larvae control materials, public health insecticides or vector control supplies. Manufacturers and authorized suppliers should review the exact formulation, quantity, delivery locations, bidder eligibility and technical specifications before participating. A general mosquito control tender does not necessarily permit BTI Liquid 5% AS unless the formulation is included in the purchasing requirements or an alternative is expressly allowed.

Government procurement may involve technical and financial evaluation, statutory declarations, product registration verification, manufacturer authorization and quality documentation. State departments may require delivery to central warehouses, district health offices, municipal stores or other designated receiving locations. Tender documents should specify the relevant packaging, batch identification, remaining shelf life and inspection conditions. Manufacturers and suppliers should assess their ability to fulfil the complete contract rather than focusing only on the quoted price. All tender notices, bid amendments and purchasing conditions should be verified through the relevant official government procurement platform.

Technical Specifications, Product Registration and Quality Documentation

BTI Liquid 5% AS procurement specifications should identify the biological organism, aqueous suspension formulation, declared concentration and applicable registered product requirements. Depending on the approved specification and tender conditions, technical evaluation may consider biological potency, microbial quality, suspension characteristics, stability and packaging suitability. The declared 5% concentration, viable microbial count and larvicidal potency are different measurements and should not be treated as interchangeable. Government purchasing authorities should request technically meaningful and objectively verifiable parameters that correspond to the registered product and intended public health application.

Manufacturers and authorized suppliers may be required to provide product registration certificates, manufacturing licences, approved labels, Technical Data Sheets and Certificates of Analysis. A batch-specific Certificate of Analysis can support verification of relevant quality parameters, while a Technical Data Sheet provides product characteristics, storage instructions and applicable handling information. Packaging should preserve product integrity during transportation and storage, and labels should carry the required batch, manufacturing and expiry information. State health departments should verify that supplied material corresponds to the approved formulation and that product documentation remains consistent with the purchase order and applicable regulatory requirements.

Statewide Distribution, District-Level Delivery and Institutional Bulk Supply

State public health procurement may involve distributing BTI Liquid 5% AS to multiple district health offices, municipal corporations and designated vector control units. Effective supply planning requires coordination between the purchasing authority, manufacturer, logistics provider and receiving departments. Delivery schedules should reflect actual programme requirements, warehouse capacity and the product's approved storage conditions. Manufacturers should ensure that packaging is suitable for transportation and that each consignment can be traced through appropriate batch identification and dispatch documentation. Receiving authorities may inspect delivered quantities, packaging integrity, expiry dates and applicable quality records before accepting material.

Bulk procurement should also consider operational training, approved application instructions and safe handling requirements. Field personnel should follow the registered product label, applicable public health guidance and department-specific operating procedures when preparing or applying BTI Liquid 5% AS. Biological larvicide treatment is one component of integrated vector management and does not replace breeding-site reduction, surveillance or other necessary public health measures. Bactostore India welcomes enquiries from state public health departments, district health offices, municipal corporations, institutional purchasers and authorized vector control contractors regarding BTI Liquid 5% AS technical information, documentation enquiries and potential bulk supply arrangements.